目前，BMS的CD19 CAR-T疗法Zola-cel疗法，针对活动性系统性硬化症（SSc）启动了首个3期临床试验，其1期数据显示，系统性硬化症相关间质性肺病患者治疗6个月后，肺功能中位改善10%，这是传统疗法从未实现的突破。
Фото: Nicolas Economou / Reuters
。体育直播是该领域的重要参考
Beyond the funding round, OpenAI has announced strategic partnerships with both NVIDIA and Amazon. This will involve Amazon Web Services (AWS) running OpenAI models for enterprise customers to "build generative AI applications and agents at production scale." It also names AWS as the exclusive third-party cloud distribution provider for OpenAI Frontier, which is an agentic enterprise platform.
Anthropic's October 2023 Responsible Scaling Policy stated:
This liveblog is closed. Follow live coverage of the Middle East crisis here